About AddLife
AddLife is a group that comprises approximately 25 operating subsidiaries that mainly operates in the Nordic Life Science market. The Life Science market can be divided in larger market areas, where the group primarily focuses in selected niches in the market areas diagnostics, medical technology and biomedical research and laboratory analysis. AddLife has operates in two business areas; Labtech and Medtech. The business area Labtech focuses on sales to the two market areas of diagnostics and biomedical research and laboratory analysis while Medtech focuses on sales to the market area medical technology. AddLife is, except from the operations in the Nordic countries, also represented by smaller businesses on the European market in Germany, the Benelux countries, Estonia and Italy.
The market is segmented and there are many competitors within the market areas where AddLife operates. Large international players offer products under their own brands in their sales offices in the Nordic market. Also smaller specialized players offer their own products in different niches. In addition there are independent players, like AddLife, that can offer tailormade solutions with products from different suppliers to the customer.
- Focus : Service
- Industry : Biotechnology
Product portfolio of AddLife
Here you will find AddLife AB
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.